Light Horse established with $62m financing, partners with Novartis
Light Horse Therapeutics has been established with a $62m Series A financing led by founding investor Versant Ventures and partnered with Novartis to identify and develop potentially advanced therapeutics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry